128 related articles for article (PubMed ID: 23566269)
1. 4-Hydroxypyridazin-3(2H)-one derivatives as novel D-amino acid oxidase inhibitors.
Hondo T; Warizaya M; Niimi T; Namatame I; Yamaguchi T; Nakanishi K; Hamajima T; Harada K; Sakashita H; Matsumoto Y; Orita M; Takeuchi M
J Med Chem; 2013 May; 56(9):3582-92. PubMed ID: 23566269
[TBL] [Abstract][Full Text] [Related]
2. Modulation of NMDA receptor function by inhibition of D-amino acid oxidase in rodent brain.
Strick CA; Li C; Scott L; Harvey B; Hajós M; Steyn SJ; Piotrowski MA; James LC; Downs JT; Rago B; Becker SL; El-Kattan A; Xu Y; Ganong AH; Tingley FD; Ramirez AD; Seymour PA; Guanowsky V; Majchrzak MJ; Fox CB; Schmidt CJ; Duplantier AJ
Neuropharmacology; 2011; 61(5-6):1001-15. PubMed ID: 21763704
[TBL] [Abstract][Full Text] [Related]
3. Discovery of isatin and 1H-indazol-3-ol derivatives as d-amino acid oxidase (DAAO) inhibitors.
Szilágyi B; Kovács P; Ferenczy GG; Rácz A; Németh K; Visy J; Szabó P; Ilas J; Balogh GT; Monostory K; Vincze I; Tábi T; Szökő É; Keserű GM
Bioorg Med Chem; 2018 May; 26(8):1579-1587. PubMed ID: 29472125
[TBL] [Abstract][Full Text] [Related]
4. D-Amino acid oxidase inhibitors based on the 5-hydroxy-1,2,4-triazin-6(1H)-one scaffold.
Hin N; Duvall B; Berry JF; Ferraris DV; Rais R; Alt J; Rojas C; Slusher BS; Tsukamoto T
Bioorg Med Chem Lett; 2016 Apr; 26(8):2088-91. PubMed ID: 26965861
[TBL] [Abstract][Full Text] [Related]
5. Discovery, SAR, and pharmacokinetics of a novel 3-hydroxyquinolin-2(1H)-one series of potent D-amino acid oxidase (DAAO) inhibitors.
Duplantier AJ; Becker SL; Bohanon MJ; Borzilleri KA; Chrunyk BA; Downs JT; Hu LY; El-Kattan A; James LC; Liu S; Lu J; Maklad N; Mansour MN; Mente S; Piotrowski MA; Sakya SM; Sheehan S; Steyn SJ; Strick CA; Williams VA; Zhang L
J Med Chem; 2009 Jun; 52(11):3576-85. PubMed ID: 19438227
[TBL] [Abstract][Full Text] [Related]
6. Interactions of the potent D-amino acid oxidase inhibitor CBIO with morphine in pain and tolerance to analgesia.
Gong N; Wang YC; Wang HL; Ma AN; Hashimoto K; Wang YX
Neuropharmacology; 2012 Sep; 63(3):460-8. PubMed ID: 22587944
[TBL] [Abstract][Full Text] [Related]
7. Is rat an appropriate animal model to study the involvement of D-serine catabolism in schizophrenia? Insights from characterization of D-amino acid oxidase.
Frattini LF; Piubelli L; Sacchi S; Molla G; Pollegioni L
FEBS J; 2011 Nov; 278(22):4362-73. PubMed ID: 21981077
[TBL] [Abstract][Full Text] [Related]
8. The behavioral and neurochemical effects of a novel D-amino acid oxidase inhibitor compound 8 [4H-thieno [3,2-b]pyrrole-5-carboxylic acid] and D-serine.
Smith SM; Uslaner JM; Yao L; Mullins CM; Surles NO; Huszar SL; McNaughton CH; Pascarella DM; Kandebo M; Hinchliffe RM; Sparey T; Brandon NJ; Jones B; Venkatraman S; Young MB; Sachs N; Jacobson MA; Hutson PH
J Pharmacol Exp Ther; 2009 Mar; 328(3):921-30. PubMed ID: 19088300
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and Biochemical Evaluation of Lid-Open D-Amino Acid Oxidase Inhibitors.
Szilágyi B; Hargitai C; Kelemen ÁA; Rácz A; Ferenczy GG; Volk B; Keserű GM
Molecules; 2019 Jan; 24(2):. PubMed ID: 30646619
[TBL] [Abstract][Full Text] [Related]
10. Converging Evidence on D-Amino Acid Oxidase-Dependent Enhancement of Hippocampal Firing Activity and Passive Avoidance Learning in Rats.
Nagy LV; Bali ZK; Kapus G; Pelsőczi P; Farkas B; Lendvai B; Lévay G; Hernádi I
Int J Neuropsychopharmacol; 2021 May; 24(5):434-445. PubMed ID: 33305805
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of D-amino acid oxidase inhibitors.
Ferraris D; Duvall B; Ko YS; Thomas AG; Rojas C; Majer P; Hashimoto K; Tsukamoto T
J Med Chem; 2008 Jun; 51(12):3357-9. PubMed ID: 18507366
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in the discovery of D-amino acid oxidase inhibitors and their therapeutic utility in schizophrenia.
Ferraris DV; Tsukamoto T
Curr Pharm Des; 2011; 17(2):103-11. PubMed ID: 21361869
[TBL] [Abstract][Full Text] [Related]
13. 6-Hydroxy-1,2,4-triazine-3,5(2H,4H)-dione Derivatives as Novel D-Amino Acid Oxidase Inhibitors.
Hin N; Duvall B; Ferraris D; Alt J; Thomas AG; Rais R; Rojas C; Wu Y; Wozniak KM; Slusher BS; Tsukamoto T
J Med Chem; 2015 Sep; 58(18):7258-72. PubMed ID: 26309148
[TBL] [Abstract][Full Text] [Related]
14. Drug discovery strategies and the preclinical development of D-amino-acid oxidase inhibitors as antipsychotic therapies.
Szilágyi B; Ferenczy GG; Keserű GM
Expert Opin Drug Discov; 2018 Oct; 13(10):973-982. PubMed ID: 30220232
[TBL] [Abstract][Full Text] [Related]
15. Active site plasticity in D-amino acid oxidase: a crystallographic analysis.
Todone F; Vanoni MA; Mozzarelli A; Bolognesi M; Coda A; Curti B; Mattevi A
Biochemistry; 1997 May; 36(19):5853-60. PubMed ID: 9153426
[TBL] [Abstract][Full Text] [Related]
16. Validation of tautomeric and protomeric binding modes by free energy calculations. A case study for the structure based optimization of D-amino acid oxidase inhibitors.
Orgován Z; Ferenczy GG; Steinbrecher T; Szilágyi B; Bajusz D; Keserű GM
J Comput Aided Mol Des; 2018 Feb; 32(2):331-345. PubMed ID: 29335871
[TBL] [Abstract][Full Text] [Related]
17. The synthesis and structure-activity relationship of pyridazinones as glucan synthase inhibitors.
Ting PC; Kuang R; Wu H; Aslanian RG; Cao J; Kim DW; Lee JF; Schwerdt J; Zhou G; Wainhaus S; Black TA; Cacciapuoti A; McNicholas PM; Xu Y; Walker SS
Bioorg Med Chem Lett; 2011 Mar; 21(6):1819-22. PubMed ID: 21316223
[TBL] [Abstract][Full Text] [Related]
18. D-amino acid oxidase inhibitors as a novel class of drugs for schizophrenia therapy.
Sacchi S; Rosini E; Pollegioni L; Molla G
Curr Pharm Des; 2013; 19(14):2499-511. PubMed ID: 23116391
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of kojic acid derivatives as secondary binding site probes of D-amino acid oxidase.
Raje M; Hin N; Duvall B; Ferraris DV; Berry JF; Thomas AG; Alt J; Rojas C; Slusher BS; Tsukamoto T
Bioorg Med Chem Lett; 2013 Jul; 23(13):3910-3. PubMed ID: 23683589
[TBL] [Abstract][Full Text] [Related]
20. Isoxazolo-[3,4-d]-pyridazin-7-(6H)-one as a potential substrate for new aldose reductase inhibitors.
Costantino L; Rastelli G; Gamberini MC; Giovannoni MP; Dal Piaz V; Vianello P; Barlocco D
J Med Chem; 1999 Jun; 42(11):1894-900. PubMed ID: 10354397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
